BLACK DIAMOND THERAPEUTICS I shareholders Q3 2023

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

BLACK DIAMOND THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
SUSQUEHANNA INTERNATIONAL GROUP, LLP 211,319$606,4860.00%
TSFG, LLC 100$10.00%
RHUMBLINE ADVISERS 449$1,2880.00%
UBS Group AG 246$7060.00%
TWO SIGMA ADVISERS, LP 28,200$80,9340.00%
FEDERATED HERMES, INC. 5,166$14,8260.00%
VANGUARD GROUP INC 1,963,583$5,635,4830.00%
Authentikos Wealth Advisory, LLC 15$430.00%
AE Wealth Management LLC 15,935$45,7330.00%
JPMORGAN CHASE & CO 1,107,583$3,178,7630.00%
Steward Partners Investment Advisory, LLC 3,750$10,7630.00%
Qube Research & Technologies Ltd 2,918$8,3750.00%
Walleye Capital LLC 15,409$44,2240.00%
Geneos Wealth Management Inc. 280$8040.00%
Beaird Harris Wealth Management, LLC 36$1040.00%
CWM, LLC 9$00.00%
OSAIC HOLDINGS, INC. 717$2,0570.00%
FMR LLC 2$60.00%
External links

This page lists BLACK DIAMOND THERAPEUTICS I's shareholders in Q3 2023. To view BLACK DIAMOND THERAPEUTICS I's shareholder history, click here.